Story no.172OngoingHealthSeriousHérault +526 Oct → 19 Nov18 facts · 62 art.
Cancer research and treatment in Europe and France
From October 27, 2026, several studies presented advances against cancer, notably second-generation hormone therapy that would extend survival by two years in metastatic prostate cancer. On October 29 and 30, after a European oncology congress, researchers highlighted both the potential of new treatments, such as a melanoma vaccine, and delays in effective access for patients. In early November, tracks of reinforced immunotherapy, HIFU ultrasound for the prostate and funding for the ATLAS team on autoantibodies were reported, while Nice researchers developed mini prostate tumors. On November 17, the European Commission authorized daraxonrasib against pancreatic cancer, but its access in France is expected in several months; meanwhile, Villejuif, Saintes and Montpellier announced equipment or projects in oncology, including BNCT. On November 18 and 19, World Pancreatic Cancer Day highlighted funded Toulouse projects and awareness of warning signs and early diagnosis.
In brief
Ongoing story bringing together 18 events nationwide, followed from 26 October 2026 to 19 November 2026. 62 articles from 23 sources (health); last updated on 19 November 2026 at 19:00.
42 articles of rated outlets · 20 unrated outside the bar · 23 sources (62 art.) · the three sides talk about it · outlets: left 4, centre 13, right 2
Angle comparison for the whole story
The comparison of angles across the entire story will be written during the next collection run.
Timeline
newest firstOutlets:LeftCentreRightUncategorised· badge = severity
In figures
Affected departments
Reported toll
Amounts cited25 000 euros · 40.000 euros · 1,5 million d'euros
Highest number recorded in 3 article(s), automatically extracted: please check sources.
Further reading
Organisations cited
Go up the thread
Events in the story
- Cancer du pancréas : sensibilisation aux signes d’alerte et au diagnostic précoce19 Nov
- Cancer de la prostate : les ultrasons HIFU remboursés ouvrent une troisième voie19 Nov
- La Commission européenne autorise le daraxonrasib contre le cancer du pancréas19 Nov
- Toulouse : trois projets de recherche sur le cancer du pancréas mis en lumière18 Nov
- Villejuif : une machine maintient en vie des foies malades pour la recherche contre le cancer18 Nov
- L'ICM confirme le déploiement de la BNCT à Montpellier17 Nov
- L'hôpital de Saintes se dote de deux nouveaux accélérateurs de particules17 Nov
- Metastatic prostate cancer: hormone therapy extends survival by two years16 Nov
- In Nice, researchers grow "mini-tumors" to fight prostate cancer16 Nov
- A promising tailor-made vaccine against melanoma recurrences8 Nov